Cargando…

Erythropoietin Receptor (EPOR) Signaling in the Osteoclast Lineage Contributes to EPO-Induced Bone Loss in Mice

Erythropoietin (EPO) is a pleiotropic cytokine that classically drives erythropoiesis but can also induce bone loss by decreasing bone formation and increasing resorption. Deletion of the EPO receptor (EPOR) on osteoblasts or B cells partially mitigates the skeletal effects of EPO, thereby implicati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Awida, Zamzam, Hiram-Bab, Sahar, Bachar, Almog, Saed, Hussam, Zyc, Dan, Gorodov, Anton, Ben-Califa, Nathalie, Omari, Sewar, Omar, Jana, Younis, Liana, Iden, Jennifer Ana, Graniewitz Visacovsky, Liad, Gluzman, Ida, Liron, Tamar, Raphael-Mizrahi, Bitya, Kolomansky, Albert, Rauner, Martina, Wielockx, Ben, Gabet, Yankel, Neumann, Drorit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570419/ https://www.ncbi.nlm.nih.gov/pubmed/36233351 http://dx.doi.org/10.3390/ijms231912051

Ejemplares similares

The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice
por: Awida, Zamzam, et al.
Publicado: (2021)

Epo/EpoR signaling in osteoprogenitor cells is essential for bone homeostasis and Epo-induced bone loss
por: Rauner, Martina, et al.
Publicado: (2021)

Erythropoietin receptor in B cells plays a role in bone remodeling in mice
por: Deshet-Unger, Naamit, et al.
Publicado: (2020)

Erythropoietin Mediated Bone Loss in Mice Is Dose-Dependent and Mostly Irreversible
por: Kolomansky, Albert, et al.
Publicado: (2020)

Anti-CD20-Mediated B Cell Depletion Is Associated With Bone Preservation in Lymphoma Patients and Bone Mass Increase in Mice
por: Kolomansky, Albert, et al.
Publicado: (2020)

The Anti-Tumorigenic Role of Cannabinoid Receptor 2 in Colon Cancer: A Study in Mice and Humans
por: Iden, Jennifer Ana, et al.
Publicado: (2023)

EpoR Activation Stimulates Erythroid Precursor Proliferation by Inducing Phosphorylation of Tyrosine-88 of the CDK-Inhibitor p27(Kip1)
por: Pegka, Fragka, et al.
Publicado: (2023)

The Anti-Tumorigenic Role of Cannabinoid Receptor 2 in Non-Melanoma Skin Cancer
por: Iden, Jennifer Ana, et al.
Publicado: (2023)

Erythropoietin enhances Kupffer cell number and activity in the challenged liver
por: Gilboa, Dafna, et al.
Publicado: (2017)

Quantification of Osteoclasts in Culture, Powered by Machine Learning
por: Cohen-Karlik, Edo, et al.
Publicado: (2021)

Therapeutic Potential of Vasoactive Intestinal Peptide and its Derivative Stearyl-Norleucine-VIP in Inflammation-Induced Osteolysis
por: Eger, Michal, et al.
Publicado: (2021)

The Effects of Curcumae Longae Radix, Curcuma phaeocaulis Radix and Their Processed Products on Epo/EpoR Pathway and CD62p
por: Chen, Zhimin, et al.
Publicado: (2018)

Local YB-1, Epo, and EpoR concentrations in fractured bones: results from a porcine model of multiple trauma
por: Bläsius, Felix Marius, et al.
Publicado: (2023)

Dynamic Ligand Modulation of EPO Receptor Pools, and Dysregulation by Polycythemia-Associated EPOR Alleles
por: Singh, Seema, et al.
Publicado: (2012)

EpoR stimulates rapid cycling and larger red cells during mouse and human erythropoiesis
por: Hidalgo, Daniel, et al.
Publicado: (2021)

Erythropoietin treatment in murine multiple myeloma: immune gain and bone loss
por: Deshet-Unger, Naamit, et al.
Publicado: (2016)

Editorial: Developmental Biology and Regulation of Osteoclasts
por: Gabet, Yankel, et al.
Publicado: (2021)

Defining an EPOR- Regulated Transcriptome for Primary Progenitors, including Tnfr-sf13c as a Novel Mediator of EPO- Dependent Erythroblast Formation
por: Singh, Seema, et al.
Publicado: (2012)

Virus-mediated EpoR76E gene therapy preserves vision in a glaucoma model by modulating neuroinflammation and decreasing oxidative stress
por: Hines-Beard, Jessica, et al.
Publicado: (2016)

Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts
por: Tankiewicz-Kwedlo, A., et al.
Publicado: (2016)

Expansion of EPOR-negative macrophages besides erythroblasts by elevated EPOR signaling in erythrocytosis mouse models
por: Wang, Jieyu, et al.
Publicado: (2018)

Functional EpoR Pathway Utilization Is Not Detected in Primary Tumor Cells Isolated from Human Breast, Non-Small Cell Lung, Colorectal, and Ovarian Tumor Tissues
por: Patterson, Scott D., et al.
Publicado: (2015)

Erythroid‐specific inactivation of Slc12a6/Kcc3 by EpoR promoter‐driven Cre expression reduces K‐Cl cotransport activity in mouse erythrocytes
por: Shmukler, Boris E., et al.
Publicado: (2022)

Low incidence of EPOR mutations in idiopathic erythrocytosis
por: Filser, Mathilde, et al.
Publicado: (2020)

Mechanism and Prevention of Titanium Particle-Induced Inflammation and Osteolysis
por: Eger, Michal, et al.
Publicado: (2018)

Different Effects of Soy and Whey on Linear Bone Growth and Growth Pattern in Young Male Sprague-Dawley Rats
por: Bar-Maisels, Meytal, et al.
Publicado: (2021)

Hematopoietic Stem Cells but Not Multipotent Progenitors Drive Erythropoiesis during Chronic Erythroid Stress in EPO Transgenic Mice
por: Singh, Rashim Pal, et al.
Publicado: (2018)

Hypoxia-Inducible Factors Regulate Osteoclasts in Health and Disease
por: Meng, Xianyi, et al.
Publicado: (2021)

Renal Proximal Tubule Cell Cannabinoid-1 Receptor Regulates Bone Remodeling and Mass via a Kidney-to-Bone Axis
por: Baraghithy, Saja, et al.
Publicado: (2021)

Derivatives of Salarin A, Salarin C and Tulearin A—Fascaplysinopsis sp. Metabolites
por: Goren Zur, Lee, et al.
Publicado: (2013)

Osteogenic growth peptide is a potent anti-inflammatory and bone preserving hormone via cannabinoid receptor type 2
por: Raphael-Mizrahi, Bitya, et al.
Publicado: (2022)

The Expression of EPOR in Renal Cortex during Postnatal Development
por: Xiao, Lu, et al.
Publicado: (2012)

Evaluation of the long-term skeletal effect induced by teratogen 5-aza-2′deoxycytidine on offspring of high (C3H/HeJ) and low (C57BL/6J) bone mass phenotype mice
por: Khajuria, Deepak Kumar, et al.
Publicado: (2018)

Erythropoietin drives breast cancer progression by activation of its receptor EPOR
por: Chan, Ka Kui, et al.
Publicado: (2017)

Genetic variants of erythropoietin (EPO) and EPO receptor genes in familial erythrocytosis
por: Vočanec, Danijela, et al.
Publicado: (2018)

Beta Palmitate Improves Bone Length and Quality during Catch-Up Growth in Young Rats
por: Bar-Maisels, Meytal, et al.
Publicado: (2017)

EPOS Abstract Book
Publicado: (2022)

Welcome to EPOS 2023
por: Sanpera, Ignacio, et al.
Publicado: (2023)

EPOS Abstract Book
Publicado: (2023)

A truncating mutation in EPOR leads to hypo-responsiveness to erythropoietin with normal haemoglobin
por: Oskarsson, Gudjon R., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_64k6dblfnp1maeujjo5ipgmjgb